(JHEM) John Hancock Multifactor - Overview
Etf: Emerging, Equity, Stocks, Markets, Depository
Dividends
| Dividend Yield | 2.52% |
| Yield on Cost 5y | 2.86% |
| Yield CAGR 5y | -0.03% |
| Payout Consistency | 89.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.0% |
| Relative Tail Risk | 0.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.84 |
| Alpha | 28.72 |
| Character TTM | |
|---|---|
| Beta | 0.621 |
| Beta Downside | 0.596 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.17% |
| CAGR/Max DD | 0.92 |
Description: JHEM John Hancock Multifactor December 30, 2025
The John Hancock Multifactor Emerging Markets ETF (JHEM) commits at least 80 % of its net assets – plus any investment-purpose borrowings – to securities that are constituents of its underlying index, including direct stocks, depositary receipts, and the underlying equities of those receipts. This structure ensures tight tracking of the index while allowing limited flexibility for cash management.
As of the latest filing, JHEM carries an expense ratio of 0.35 % and manages roughly $850 million in assets, positioning it among the mid-size EM-focused ETFs. The fund’s top sector exposures are technology (≈22 % of assets), consumer discretionary (≈18 %), and financials (≈15 %), reflecting the index’s tilt toward higher-growth, higher-volatility segments of emerging economies.
Key macro drivers that will likely influence JHEM’s performance include: (1) real-GDP growth in emerging markets, which the IMF projects at an average 4.7 % for 2024-2025, outpacing developed-market growth; (2) commodity price trends, especially for copper and iron ore, as many holdings are tied to resource-rich economies; and (3) currency risk, given that a sizable portion of the portfolio is denominated in local currencies that can appreciate or depreciate sharply against the USD.
For a deeper, data-driven assessment of JHEM’s risk-adjusted returns and factor exposures, you may find the analytics on ValueRay worth exploring.
What is the price of JHEM shares?
Over the past week, the price has changed by +1.55%, over one month by +5.47%, over three months by +9.72% and over the past year by +38.50%.
Is JHEM a buy, sell or hold?
What are the forecasts/targets for the JHEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.6 | 13.5% |
JHEM Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 685.0m USD (685.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 685.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 685.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.20% (E(685.0m)/V(685.0m) * Re(8.20%) + (debt-free company))
Discount Rate = 8.20% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)